Cutivate Lotion HPA Axis Pediatric Study

Completed · Phase 4

Conditions studied: Atopic Dermatitis

In brief

A multi-center, open-label, Phase IV, unblinded study using Cutivate (fluticasone propionate, 0.05%)lotion and it's possible effects on the HPA axis of infants diagnosed with atopic dermatitis.

Key facts

Study ID
NCT00546000
Run by
Fougera Pharmaceuticals Inc.
People needed
56
Starts
2007-07-01
Expected to finish
2008-12-01
Last updated by the study team
2014-07-24

Who can join

Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.